Skip to main content

Aspire Biopharma Holdings, Inc.

ASBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001847345

No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.

Other share classesASBPW

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, −2 vs. previous quarter
13
13F valueReported value at the end of Q2 2026
$250.9K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding ASBP, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding ASBP at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Aspire Biopharma Holdings, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 10, 2025 (view filing)5:25 PM ETJun 4-56 daysFell Donald G.DirectorPPurchaseCommon Stock, par value $0.0001+20.0K$0.39+$7.80KNew position20.0K afterAmended2 lots
Aug 22, 2023 (view filing)Aug 184 daysPowerUp Sponsor LLC10% OwnerSSaleClass A Ordinary Shares, par value $0.0001−4.32M––−60.1%2.87M after

Top 10 13F holders, Q2 2026

The largest institutional positions in Aspire Biopharma Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 13 holders
Institutions holding ASBP in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Jane Street Group, LLC14,830$79.2K0.00%+14,830New
Geode Capital Management, LLC10,474$55.9K0.00%−32,910−75.9%Reduced
Vanguard Capital Management LLC10,408$55.6K0.00%+2,549+32.4%Added
Vanguard Fiduciary Trust Co10,081$53.8K0.00%+7,225+253.0%Added
Crewe Advisors LLC677$3.62K0.00%−19,658−96.7%Reduced
Tower Research Capital LLC (TRC)283$1.51K0.00%−1,891−87.0%Reduced
Toronto Dominion Bank166$8860.00%−4,834−96.7%Reduced
Hallmark Capital Management Inc33$1760.00%−967−96.7%Reduced
Crossingbridge Advisors, LLC20$1070.00%−24,328−99.9%Reduced
SBI Securities Co., Ltd.2$110.00%+1+100.0%Added